RTP-based Metabolon (www.metabolon.com) launched mVivo™, a service that allows researchers to gain a deeper understanding of the effects of investigational drugs during animal testing. With the introduction of mVivo, Metabolon completes their three product series of metabolomic drug safety and efficacy testing solutions, spanning the entire drug discovery and development workflow.
By analyzing microgram or microliter quantities of the target samples routinely isolated for evaluation, mVivo analysis provides valuable, non-biased information about a drug’s on- and off-target effects during animal studies.